Coeptis Therapeutics, Inc. Proceeds from Notes Payable
Coeptis Therapeutics, Inc. reported Proceeds from Notes Payable of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2022-11-08
- Coeptis Therapeutics, Inc. proceeds from notes payable for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Coeptis Therapeutics, Inc. proceeds from notes payable for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Coeptis Therapeutics, Inc. proceeds from notes payable for the quarter ending 2022-03-31 was $0.00.
- Coeptis Therapeutics, Inc. proceeds from notes payable for the quarter ending 2021-12-31 was -$4.75M.
- Coeptis Therapeutics, Inc. proceeds from notes payable for fiscal 2021 was $77.59K, a 93.68% decline from fiscal 2020.
- Coeptis Therapeutics, Inc. proceeds from notes payable for fiscal 2020 was $1.23M.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | -$4.75M derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $0.00 10-Q · filed 2022-08-02 | -$4.75M derived: sum of 3 quarters · filed 2022-08-02 | $0.00 derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | -$4.75M derived: sum of 2 quarters · filed 2022-05-12 | $0.00 derived: sum of 3 quarters · filed 2022-11-08 | $77.59K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-12-31 | -$4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $77.59K derived: sum of 3 quarters · filed 2022-11-08 | $77.59K 10-K · filed 2022-03-11 |
| 2021-09-30 | $4.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $4.83M derived: sum of 2 quarters · filed 2022-11-08 | $4.83M 10-Q · filed 2022-11-08 | $4.83M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $77.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $77.59K 10-Q · filed 2022-08-02 | $77.59K derived: sum of 3 quarters · filed 2022-08-02 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.23M 10-K · filed 2022-03-11 | ||
| 2020-09-30 | $1.23M 10-Q · filed 2021-11-15 |